Newsroom | Albert Einstein College of Medicine

News Release

Einstein Pathway Programs Awarded $3.25 Million Grant to Support Expansion and New Initiatives

News Release

Montefiore Einstein Comprehensive Cancer Center Awarded Comprehensive Designation from the National Cancer Institute

News Release

World-Renowned Scientist and Researcher Yaron Tomer, MD, Named the Marilyn and Stanley M. Katz Dean

News Release

New Test Shows Promise for Detecting Hard-to-Find Cervical Cancers

News Release

Discovery of Chikungunya Virus’s “Invisibility Shield” May Lead to Vaccines or Treatments

News Releases

Montefiore Einstein Comprehensive Cancer Center Awarded FDA Grant for Clinical Trial on Experimental AML/MDS Treatment

Tuesday, November 28, 2023

Hope for Eradicating Dormant but Deadly Cancer Cells

Monday, November 20, 2023

Women in Research: New Philanthropic Support for Early- and Mid-Career Female Faculty

Wednesday, November 15, 2023

Facts & Stats

Expert List for Media

Robert W. Marion, M.D.

Area(s) of expertise: Genetic diseasesAutismSudden infant death syndrome (SIDS) and Cardiogenetics

Dr. Marion is an internationally recognized pediatric geneticist who specializes in diagnosing and treating children with autism spectrum disorders and genetic diseases. His work with the Aguirre brothers, twins who were joined at the head… Learn more

Find experts available for media

Einstein in the News

Less Snacking, More Satisfaction: Some Foods Boost Levels of an Ozempic-Like Hormone

Gary Schwartz, Ph.D., describes how GLP-1, a hormone that is released during digestion, acts to stimulate insulin and slow how quickly food moves through the stomach into the intestine. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.

More coverage on Dr. Schwartz

Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change

Sriram Machineni, M.B.B.S., comments on the results of a study he co-authored on the effectiveness of a phase III trial for tirzepatide, a weight loss drug, which helped study participants lose a significant amount of weight following a diet and exercise program. Dr. Machineni is associate professor of medicine and director of the Fleischer Institute Medical Weight Center at Einstein and Montefiore.

Additional coverage includes Medscape

Black Patients 42% More Likely to Die After High-Risk Surgery Than White Patients

Tracey Straker, M.D., comments on a study that found high-risk surgeries are more deadly for Black and Hispanic Americans than their white counterparts, noting that social determinants of health, such as lack of insurance, play a role in the disparities. Dr. Straker is professor and chief of anesthesiology at Einstein and Montefiore.

More coverage on Dr. Straker

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

Contact Us

Deirdre Branley
Director, Strategic Communications and Media Relations
718.430.2923
deirdre.branley@einsteinmed.edu

Elaine Iandoli
Science Media Relations Manager
718.430.4137
elaine.iandoli@einsteinmed.edu

Montefiore Newsroom

Albert Einstein College of Medicine

Tweets about @EinsteinMed

Einstein-Montefiore Timeline

Albert Einstein College of Medicine, a part of Montefiore, is a premier, research-intensive medical school dedicated to innovative biomedical investigation and to the development of ethical and compassionate physicians and scientists. Inspired by the words of our namesake, we have from our inception welcomed students, faculty and staff from diverse backgrounds who strive to enhance human health in the community and beyond. This is an attribute in which Albert Einstein took great pride when consenting to the use of his name in conjunction with the medical school.

Einstein’s first medical school class

1955

Two years after scientist and humanitarian Albert Einstein agrees to lend his name to a new medical school, the College of Medicine welcomes its first class of students (pictured here on graduation day, 1959).

Einstein affiliates with Montefiore

1963

Einstein affiliates with Montefiore. Seated, from left: Jacob W. Schwab, president, Montefiore Hospital; Samuel Belkin, Ph.D., president, Yeshiva University. Standing, from left: Marcus D. Kogel, M.D., dean, Albert Einstein College of Medicine; Martin Cherkasky, M.D., director, Montefiore.

Montefiore assumes operation Weiler Hospital

1969

Montefiore assumes operational responsibility for Einstein’s Jack D. Weiler Hospital.

Departments of medicine merge

1980

The Einstein and Montefiore departments of medicine merge, combining the strengths of both campuses. Louis Sherwood, M.D., becomes the first unified chair of medicine.

Montefiore employs joint faculty

1990

Montefiore employs joint Einstein-Montefiore faculty.

Reaffirming the partnership

2009

Dean Allen M. Spiegel, M.D., and Steven M. Safyer, M.D., president and CEO of Montefiore, sign a renewal agreement reaffirming the partnership between Einstein and Montefiore. The two institutions agree that Einstein will administer research grants awarded to Montefiore.

Einstein and Montefiore jointly recruit faculty

2012-2014

Continuing the effort begun in 1977 to develop unified departments, each headed by a single chair, Einstein and Montefiore jointly recruit Judy L. Aschner, M.D. (pediatrics), pictured at right; Mark P. Schoenberg, M.D. (urology); Matthew N. Bartels, M.D. (physical medicine and rehabilitation); and Sharmila K. Makhija, M.D. (obstetrics & gynecology and women’s health).

Yeshiva University-Montefiore agreement finalized

2015

The YU-Montefiore agreement is finalized. Montefiore has operational and financial responsibility for Einstein, and Einstein becomes its own legal entity. Transfer to Montefiore of Einstein clinical programs (e.g., the Division of Substance Abuse, the Children’s Evaluation and Rehabilitation Center) is complete.